Video Experimental Relacionado
Updated: Jul 4, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Hidatidosis cardíaca que imita la enfermedad isquémica del corazón: un informe de caso
Andres Chaponan-Lavalle1, Cherie Quiroz Cortegana2, Luis Ivan Gordillo Velasquez2
1Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
IDCases
|February 20, 2026
Resumen
La equinococosis quística (EC) rara vez afecta al corazón, pero plantea desafíos. La extirpación quirúrgica y la medicación trataron con éxito un quiste hidatídeo cardíaco en una mujer peruana, destacando la necesidad de conciencia en áreas endémicas.
Área de la Ciencia:
- Cardiología Cardiología.
- Parasitología Parasitología.
- Enfermedades infecciosas Enfermedades infecciosas.
Sus antecedentes:
- La equinococosis quística (EC), causada por *Echinococcus granulosus*, es una enfermedad parasitaria zoonótica.
- La participación cardíaca en la EC es rara (<2% de los casos), pero clínicamente significativa y difícil de manejar.
- El diagnóstico y el tratamiento tempranos son cruciales para obtener resultados favorables en la EC cardíaca.
Objetivo del estudio:
- Para informar de un raro caso de equinococosis quística cardíaca.
- Para resaltar las estrategias de diagnóstico y manejo de la hidatidosis cardíaca.
- Para enfatizar la importancia de considerar la EC en pacientes con masas cardíacas y síntomas relevantes.
Principales métodos:
- Un estudio de caso de una mujer de 44 años con dolor torácico por esfuerzo y anomalías en el ECG.
- Las imágenes de diagnóstico revelaron una masa quística en el ventrículo izquierdo.
- La serología de Western Blot confirmó la EC, seguida de una extirpación quirúrgica y un tratamiento con albendazol.
Principales resultados:
- Se identificó una gran masa quística multilocada con calcificaciones en la pared ventricular izquierda.
- La histopatología confirmó un quiste hidatídeo no viable.
- El paciente experimentó una recuperación sin incidentes y se mantuvo asintomático a los 16 meses de seguimiento.
Conclusiones:
- Se debe considerar la hidatidosis cardíaca en regiones endémicas para pacientes que presentan síntomas similares a la angina y masas cardíacas.
- El manejo multidisciplinario que involucra cirugía y medicamentos antiparasitarios es efectivo.
- El aumento de la conciencia pública y la educación médica son vitales para mejorar el manejo de la EC cardíaca.
Videos de Conceptos Relacionados
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...